This article was written by 13.47K Followers Follow Dale Roberts is the Chief Disruptor at the Cut The Crap Investing blog. Cut The Crap
Latest News
Giannis Antetokounmpo launches venture capital fund for investments in sports and entertainment
MILWAUKEE (AP) — Giannis Antetokounmpo is looking for some assists off the court, aiding with investments in early stage startup companies. The Milwaukee Bucks
9 Best Real Estate Mutual Funds Of November 2024
Real estate is a reliable asset class commonly found in diversified investment portfolios. While real estate mutual funds don’t lead in price appreciation or
Mutual funds attempt to beat market blues with NFOs
Notwithstanding the bearish market trend and looming economic uncertainty, mutual funds have lined up 15 new fund offers to woo investors who are sitting
US economic output hits highest level since April 2022 amid 'greater optimism' among businesses
US economic output is roaring as businesses prepare for lower interest rates and the incoming Trump administration in Washington. S&P Global’s flash US composite
Move Over SCHD: 2 Game-Changing High-Yield ETFs Investors Can't Ignore
This article was written by 113.79K Followers Follow Dividend Sensei (Adam Galas) is an Army veteran and stock analyst with 20+ years of market
Here’s My Top Stock to Buy Right Now
While there are many great stocks available, there can only be one “best stock to buy.” Narrowing it down was difficult, but I think
Wall Street veteran Alex Green issued a warning to Americans who only invest in dividend stocks — here’s why he believes they’re missing out on bigger opportunities
Green noted that while “there are a lot of great dividend-paying stocks out there”, he would equally “warn people not to invest exclusively in
NOBL: Dividend Aristocrats Are Riskier Than Ever
NOBL’s 2% yield is unattractive compared to alternatives, and its equal weighting doesn’t mitigate the low yield issue. Explore more details here.
3 Dividend Stocks That Are Screaming Buys in November
Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.